🇺🇸 FDA
Patent

US 10675324

Compositions and methods for modulating AT2R activity

granted A61KA61K31/7088A61K38/08

Quick answer

US patent 10675324 (Compositions and methods for modulating AT2R activity) held by NOVOPYXIS INC. expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
NOVOPYXIS INC.
Grant date
Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/7088, A61K38/08, A61K47/10, A61K48/005